News and Media

MMS HOLDINGS EXECUTIVE MICHELLE GAYARI JOINS ADVISORY BOARD OF INTERNATIONAL NONPROFIT THAT PROVIDES EDUCATIONAL PROGRAMS TO CHILDREN IN HOSPITALS

MMS HOLDINGS EXECUTIVE MICHELLE GAYARI JOINS ADVISORY BOARD OF INTERNATIONAL NONPROFIT THAT PROVIDES EDUCATIONAL PROGRAMS TO CHILDREN IN HOSPITALS

CANTON, Mich. (October 23, 2019) – MMS Holdings – an award-winning, data-focused CRO – announced today that its Executive Director of Global Operations Michelle Gayari has joined the advisory board for the international 501(c)(3) charity Together Educating All Children in Hospitals (TEACH). As its sole board member in the state of Michigan, Gayari will provide leadership, guidance, and fundraising support to help in bringing exciting, hands-on educational programs to children in hospitals.

MMS Holdings Launches New Time-Saving Application to Automatically Perform Quality Control and Style Checks for Medical Writers

MMS Holdings Launches New Time-Saving Application to Automatically Perform Quality Control and Style Checks for Medical Writers

CANTON, Mich. (June 27, 2019) – MMS announced today the launch of Automatiqc™ (pronounced: automatic). Automatiqc is a new cloud-based application that automatically performs quality control (QC) and style checks for medical writing, pharmacovigilance, clinical trial transparency, and other types of documents in the pharmaceutical, biotechnology, and medical device industries.

Dr. Mike Poole Joins the Board of Scientific Advisors at Top Global CRO MMS Holdings

Dr. Mike Poole Joins the Board of Scientific Advisors at Top Global CRO MMS Holdings

SEATTLE (May 23, 2019) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today the addition of Dr. Mike Poole, MD, FACP to its board of scientific advisors. Currently a venture partner at Biomatics Capital, Inc., Dr. Poole has more than 25 years of experience in the pharmaceutical industry, most recently having led external investments in the Office of the President for Global Health at the Bill and Melinda Gates Foundation.

BREAKING NEWS: MMS partners with MIT Julia Lab and University of Maryland to create the Health Analytics Collective

BREAKING NEWS: MMS partners with MIT Julia Lab and University of Maryland to create the Health Analytics Collective

by MIT news, January 25, 2019
The timeline to market a new drug or medical device, from the point of discovery to U.S. Food and Drug Administration approval, can stretch to a decade. By pooling its industry experience and technology, a new health research supergroup led by the Julia Lab within the MIT Computer Science and Artificial Intelligence Laboratory aims to significantly shorten the approval process for pharmaceutical and health care groups.

Media Contact

Don McLean, MBA
Sr. Manager, Global Marketing & Communications
6880 Commerce Blvd.
Canton, MI 48187 USA
734. 245.0165
media@mmsholdings.com

 

6880 Commerce Blvd.
Canton, MI 48187 USA
734.245.0310 T
734.245.0320 F

Email Us

FacebookLinkedIn

Learn more about working with MMS

11 + 5 =

© MMS Holdings Inc. All rights reserved. Privacy Policy